GlycoGenetics

GlycoGenetics, Inc. is a biotechnology company based in Taoyuan City, Taiwan, specializing in glycobiology—the study of the structure, function, and biology of carbohydrates in the context of human health.Established in 2017, the company focuses on applying glycobiology to address unmet medical needs.

Core Technologies and Services

The company employs genetics-enabled technologies to decipher the complex glycocodes of human biology. Their offerings include:

• Development of Recombinant Human Lectins: Creating a curated collection of recombinant human lectins to profile human glycoprofiles.
• Human Glycoprofile Collection: Utilizing these lectins to determine cell surface glycoprofiles through multiplexed flow cytometry.
• Lectin-Glycome Interaction Mapping: Accessing human lectin-glycome interactions to provide insights into genetically linked information of changes in lectin-glycome interactions caused by disrupting glycogenes.
• RIFFLIE Technique: Engineering lectins of interest using Recombinational Incision For Functional Lead Evolution (RIFFLIE) for enhanced cellular functions.

These technologies aim to facilitate the identification of biomarkers or drug candidates and support therapeutic development through glyco-immunomodulatory mechanisms.

Products and Services

GlycoGenetics provides:

• Recombinant Human Lectins: For glycoprofiling and biomarker discovery.
• Flow Cytometry Services: For analyzing cell surface glycoprofiles.
• Lectin Engineering: Using the RIFFLIE technique to enhance lectin functionalities.
• Custom Research Services: Tailored solutions for specific glycobiology research needs